Top compounds associated with response to RFNG


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA PF-750 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.034 0.3
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.032 0.3
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.034 0.3
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC 0.073 0.3
mRNA BMS-345541 GDSC1000 pan-cancer AAC -0.03 0.3
mRNA ETP-46464 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.034 0.3
Download CSV